HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
Simcere Pharma (02096) spent 4.1823 million Hong Kong dollars on April 16 to repurchase 546,000 shares.
16/04/2025
GMT Eight
SIMCERE PHARMA (02096) announced that on April 16, 2025, the company repurchased 546,000 shares at a cost of HK$4.1823 million.
After Pershing Square disclosed a large stake, shares of Hertz Global Holdings Inc (HTZ.US) soared in pre-market trading.
Eli Lilly's (LLY.US) pembrolizumab injection new indication application has been accepted by the CDE.
RECOMMEND
CEOVU (00798) released its 2024 annual report: The operating cash flow has been positive for six consecutive years and the potential for development of the agile customization model is enormous.
18/04/2025
Zhejiang Reclaim Construction Group (002586.SZ): The company's stock has been subjected to additional risk warning measures.
18/04/2025
Under the economic dark cloud, who is happy and who is sad among the American oil giants? Goldman Sachs identifies two big winners.
18/04/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact:
[email protected]